Pictet Asset Management Holding Sa Denali Therapeutics Inc. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 13,796 shares of DNLI stock, worth $401,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,796
Previous 13,796
-0.0%
Holding current value
$401,877
Previous $283,000
13.07%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DNLI
# of Institutions
214Shares Held
121MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$401 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$384 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$330 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$286 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$208 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.91B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...